Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

Among patients with a myocardial infarction and a left ventricular ejection fraction of at least 40%, beta-blocker therapy led to a lower risk of death or major adverse cardiovascular events than no beta-blocker therapy. (Funded by the Health South-East research program in Norway and others; BETAMI-DANBLOCK ClinicalTrials.gov numbers, NCT03646357 and NCT03778554.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-08-30
DOI
https://doi.org/10.1056/nejmoa2505985
Citations
46
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
63.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

Karsten Tange Veien, Hans Erik Bøtker, Nikolaj T. Krarup, Ellen Bøhmer et al.
46 citations
New England Journal of Medicine
Heart Failure Treatment and Management
63.86
article

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

Karsten Tange Veien, Hans Erik Bøtker, Nikolaj T. Krarup, Ellen Bøhmer, Arnhild Bakken, Svend Eggert Jensen, Therese Lucia Friis Holmager, Jawdat Abdulla, Finn Gustafsson, Gro Egholm, Mette Rauhe Mouridsen, Morten Wang Fagerland, Michael Mæng, Morten Bøttcher, Jarle Jortveit, Anna Meta Dyrvig Kristensen, Monica Petronela Poenaru, Erick Borg, Terje K. Steigen, Kjell Vikenes, Toril Dammen, Jens Brønnum-Schou, Erik Øie, Bjørn Bendz, T S G Sehested, Gunnar Gislason, Henrik Schirmer, Ståle H. Nymo, Kristian Korsgaard Thomsen, Vegard Tuseth, Nils Tore Vethe, P. Deeg, Rune Wiseth, Kristoffer Andresen, Thomas Engstrøm, Michael Hecht Olsen, Ann Bovin, Theis Lange, Vidar Ruddox, Alf Inge Larsen, Mette Bertelsen, Dan Atar, Thor Edvardsen, Jess Lambrechtsen, Morten Krogh Christiansen, Peter Stæhr, D J Mikkelsen, Ann‐Dorthe Zwisler, Christian Tobias Torp-Pedersen, Alf‐Åge R. Pettersen, Eva Prescott, Louise Lind Schierbeck, Cédric Davidsen, John Munkhaugen, Martin Snoer, Camilla Lyngby Kjærgaard, Jens Dahlgaard Hove, Kjeld Kristensen, Mogens Lytken Larsen, Lia E. Bang, Jan Erik Otterstad, Anja Otrebska Brattrud, Ghassan Jadou
article en
46 citations

Abstract

Among patients with a myocardial infarction and a left ventricular ejection fraction of at least 40%, beta-blocker therapy led to a lower risk of death or major adverse cardiovascular events than no beta-blocker therapy. (Funded by the Health South-East research program in Norway and others; BETAMI-DANBLOCK ClinicalTrials.gov numbers, NCT03646357 and NCT03778554.).

New England Journal of MedicineVol. 393(19)
University of Copenhagen (DK), Oslo University Hospital (NO), University Hospital of North Norway (NO), University of Oslo (NO), Aarhus University (DK), Norwegian University of Science and Technology (NO), Innlandet Hospital Trust (NO), Aalborg University Hospital (DK), Stavanger University Hospital (NO), Akershus University Hospital (NO), Drammen Hospital (NO), Vestre Viken Hospital Trust (NO), Haukeland University Hospital (NO), Amager Hospital (DK), Frederiksberg Hospital (DK), Odense University Hospital (DK), Nordland Hospital Trust (NO), Herlev Hospital (DK), Hvidovre Hospital (DK), Glostrup Hospital (DK), Sykehuset i Vestfold (NO), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), North Denmark Region (DK), Zealand University Hospital (DK), Regionshospitalet Viborg (DK), Sørlandet Hospital Arendal (NO), Regionshospital Nordjylland (DK), St Olav's University Hospital (NO), Slagelse Hospital (DK), Regional Hospital Horsens (DK), Diakonhjemmet Hospital (NO), Kolding Hospital (DK), Hospital South West Jutland (DK), Lillebaelt Hospital (DK), Holbæk Sygehus (DK), Sygehus Sønderjylland (DK), Østfold Hospital Trust (NO), University of Bergen (NO)
Hjerteforeningen, Norges Forskningsråd, Novo Nordisk Fonden
Good health and well-being
Openalex Percentile: Top 0%
Heart Failure Treatment and Management
63.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.